- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Ansamitocins, maytansinoid antitumor antibiotics producing organism, fermentation, and antimicrobial activities.
-
- TANIDA SEIICHI
- Microbiological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
- HASEGAWA TORU
- Microbiological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
- HATANO KAZUNORI
- Microbiological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
- HIGASHIDE EIJI
- Microbiological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
-
- YONEDA MASAHIKO
- Microbiological Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
Bibliographic Information
- Other Title
-
- Ansamitocins Maytansinoid Antitumor Ant
Search this article
Description
Ansamitocins are new maytansinoid antitumor antibiotics produced by an actinomycete strain No. C-15003 (N-1). The organism is characterized by coremia formation on solid media, release of the rod-shaped motile spores with peritrichous flagella in liquid media, the formation of some branched mycelia at a later stage of growth in liquid culture which break up into motile elements, lysozyme resistance, the occurrence of meso-diaminopimelic acid in the cell wall, and guanine-cytosine content of 71±1 mol %. From these results, the organism has been designated as Nocardia sp. No. C-15003 (N-1). In the fermentation fluids, activity against eukaryotic microorganisms was detected. Three of the purified materials, which have the activity against Tetrahymena pyriformis strain W and Hamigera avellanea IFO 7721, were new ansamycin antibiotics with antileukemic activities and were named ansamitocins P-3, P-3' and P-4. Ansamitocins show growth inhibitory activity against several eukaryotic microorganisms but no activity against prokaryotic microorganisms. The acyl moieties at the C-3 position of ansamitocins are essential for their antifungal activities.
Journal
-
- The Journal of Antibiotics
-
The Journal of Antibiotics 33 (2), 192-198, 1980
JAPAN ANTIBIOTICS RESEARCH ASSOCIATION
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204150122496
-
- NII Article ID
- 130003409091
-
- NII Book ID
- AA0069330X
-
- COI
- 1:CAS:528:DyaL3cXhsl2jsLk%3D
-
- ISSN
- 18811469
- 00218820
-
- NDL BIB ID
- 2208992
-
- PubMed
- 7380728
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed